9 results for "Kate E. Foley"
Showing 1–9 · 0.38 seconds · RSS
-
Journal Article
Three major effects of APOEε4 on Aβ immunotherapy induced ARIA
The targeting of amyloid-beta (Aβ) plaques therapeutically as one of the primary causes of Alzheimer’s disease (AD) dementia has been an ongoing effort spanning decades. While some antibodies are extremely promising and have been moved out of clinical trials and into the clinic, most of these…
-
Journal Article
Acute anti‐Aβ antibody exposure induces microglial changes and significantly alters chemokine signaling
Abstract INTRODUCTION While the anti‐amyloid‐lowering immunotherapies provide the first disease‐targeting therapies for the treatment of Alzheimer's disease, there remain harmful adverse events causing hesitation among patients, families, physicians, and regulatory bodies. Though these drugs have…
-
Journal Article
Transcriptional profiling predicts running promotes cerebrovascular remodeling in young but not midlife mice
Abstract Background The incidence of dementia and cognitive decline is increasing with no therapy or cure. One of the reasons treatment remains elusive is because there are various pathologies that contribute to age-related cognitive decline. Specifically, with Alzheimer’s disease, targeting to…
-
Journal Article
APOE ε4 and exercise interact in a sex‐specific manner to modulate dementia risk factors
Abstract Introduction Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for Alzheimer's disease and related dementias (ADRDs), affecting many different pathways that lead to cognitive decline. Exercise is one of the most widely proposed prevention and intervention strategies to…
-
Journal Article
The APOEε3/ε4 Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice
IntroductionRestrictions on existing APOE mouse models have impacted research toward understanding the strongest genetic risk factor contributing to Alzheimer’s disease (AD) and dementia, APOEε4, by hindering observation of a key, common genotype in humans – APOEε3/ε4. Human studies are typically…
-
Journal Article
A novel mouse model expressing human forms for complement receptors CR1 and CR2
Abstract Background The complement cascade is increasingly implicated in development of a variety of diseases with strong immune contributions such as Alzheimer’s disease and Systemic Lupus Erythematosus. Mouse models have been used to determine function of central components of the complement…
-
Journal Article
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H
Late-onset Alzheimer’s disease (AD; LOAD) is the most common human neurodegenerative disease, however, the availability and efficacy of disease-modifying interventions is severely lacking. Despite exceptional efforts to understand disease progression via legacy amyloidogenic transgene mouse models…